Monza, Italy

Lino Sivieri

This inventor holds 1 USPTO granted patent. Top assignee: Chementecno S.r.l.. Active years: 2005.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Lino Sivieri. Retrieved from https://idiyas.com/inventor/lino-sivieri-sb6k4u3u

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2005

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Lino Sivieri: Innovator in Pharmaceutical Chemistry

Introduction

Lino Sivieri is a notable inventor based in Monza, Italy. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative processes. His work focuses on the preparation of pharmaceutically acceptable salts, which are crucial for drug formulation.

Latest Patents

Lino Sivieri holds a patent for a process titled "Process for the preparation of pharmaceutically acceptable salts of (R,S)-S-adenosyl-L-methionine." This invention allows for the preparation of salified (R)-(+)-S-adenosyl-L-methionine diasteroisomer in amounts lower than or equal to 3% compared to the salified (S)-(+)-S-adenosyl-L-methionine diastereoisomer. The salts produced by this process maintain their configuration stability over time, which is essential for pharmaceutical applications. He has 1 patent to his name.

Career Highlights

Lino Sivieri is associated with Chementecno S.r.l., where he applies his expertise in pharmaceutical chemistry. His work has been instrumental in advancing the methods used in drug formulation and development.

Collaborations

Lino has collaborated with notable colleagues such as Marco Berna and Gianni Santambrogio. Their combined efforts have contributed to the success of various projects within their field.

Conclusion

Lino Sivieri's innovative work in pharmaceutical chemistry exemplifies the importance of advancements in drug formulation. His contributions continue to impact the industry positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…